Various interferon (IFN)-inducible transmembrane (IFITM) proteins for COVID-19, is there a role for the combination of mycophenolic acid and interferon?
Biochimie
; 177: 50-52, 2020 Oct.
Article
in English
| MEDLINE | ID: covidwho-713261
ABSTRACT
Various interferon (IFN)-inducible transmembrane (IFITM) proteins are known to be expressed in human tissues though only IFITM 1-3 are inducible by IFN. Numerous studies have shown that activation of IFITM3 could suppress infection by influenza and coronaviruses such as the Middle East Respiratory Syndrome Coronavirus (MERS-CoV). In view of the potential application of IFITM proteins' induction to target SARS-CoV-2 infection that causes COVID-19, this article layout insights into the known antiviral mechanisms and therapeutic agents related to IFITM. Blocking viral entry through various mechanisms and the potential application of the FDA approved immunosuppressant agent, mycophenolic acid, as inducer of IFITM3 are among those discussed.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Interferons
/
RNA-Binding Proteins
/
Coronavirus Infections
/
Betacoronavirus
/
Membrane Proteins
/
Mycophenolic Acid
Limits:
Animals
/
Humans
Language:
English
Journal:
Biochimie
Year:
2020
Document Type:
Article
Affiliation country:
J.biochi.2020.08.006
Similar
MEDLINE
...
LILACS
LIS